摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-甲基苯并呋喃-2-羧酸 | 10242-09-8

中文名称
5-甲基苯并呋喃-2-羧酸
中文别名
——
英文名称
5-methylbenzofuran-2-carboxylic acid
英文别名
5-methyl-1-benzofuran-2-carboxylic acid
5-甲基苯并呋喃-2-羧酸化学式
CAS
10242-09-8
化学式
C10H8O3
mdl
——
分子量
176.172
InChiKey
RNTYTQILDXWFLQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    238-240℃
  • 沸点:
    332.1±22.0 °C(Predicted)
  • 密度:
    1.303

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    50.4
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2932999099
  • 危险性防范说明:
    P233,P260,P261,P264,P270,P271,P280,P301+P312,P302+P352,P304,P304+P340,P305+P351+P338,P312,P321,P330,P332+P313,P337+P313,P340,P362,P403,P403+P233,P405,P501
  • 危险性描述:
    H315,H319,H335
  • 储存条件:
    2-8°C,干燥保存。

SDS

SDS:de0d2f8b3cd2a9530f1312fe25b5886d
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5-甲基苯并呋喃-2-羧酸 在 sodium amalgam 作用下, 以 sodium hydroxide 为溶剂, 反应 2.5h, 生成 5-甲基-2,3-二氢苯并呋喃-2-羧酸
    参考文献:
    名称:
    .alpha.-Adrenoceptor reagents. 2. Effects of modification of the 1,4-benzodioxan ring system on .alpha.-adrenoreceptor activity
    摘要:
    Modification of the 1,4-benzodioxan ring present in RX 781094 has not previously been considered. This paper describes a number of analogues of this ring system, including compounds in which one of the oxygen atoms has been replaced by a methylene group and also those in which the ring size has been changed to give, for example, furan and thiophene derivatives. The dihydrobenzofuranylimidazoline compound 7 is the only analogue possessing presynaptic antagonist potency potency and selectivity comparable to that of 1. In view of this result, a number of derivatives was prepared to determine the structure-activity relationships within this series. Many derivatives, as well as the parent compound 7, were found to possess presynaptic alpha 2-adrenoreceptor antagonist and postsynaptic alpha 1-adrenoreceptor partial agonist properties. Two of the selective presynaptic antagonists, 13 and 14 possess greater potency and selectivity than that possessed by 1. The 5-chloro derivative 25 is twice as potent as after oral administration but only about half as potent when given intravenously.
    DOI:
    10.1021/jm00371a003
  • 作为产物:
    描述:
    参考文献:
    名称:
    Synthetic Approaches to Benzofuran Containing Insulin Sensitivity Enhancer Compounds for Treatment of Type II Diabetes
    摘要:
    DOI:
    10.3987/com-97-7820
点击查看最新优质反应信息

文献信息

  • Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
    申请人:Tachdjian Catherine
    公开号:US20050084506A1
    公开(公告)日:2005-04-21
    The present invention relates to the discovery that certain non-naturally occurring, non-peptide amide compounds and amide derivatives, such as oxalamides, ureas, and acrylamides, are useful flavor or taste modifiers, such as a flavoring or flavoring agents and flavor or taste enhancer, more particularly, savory (the “umami” taste of monosodium glutamate) or sweet taste modifiers,—savory or sweet flavoring agents and savory or sweet flavor enhancers, for food, beverages, and other comestible or orally administered medicinal products or compositions.
    本发明涉及发现,某些非天然存在的非肽酰胺化合物和酰胺衍生物,如草酰胺、脲和丙烯酰胺,可用作风味或口味调节剂,例如风味或调味剂和风味或口味增强剂,更具体地说,是用于食品、饮料和其他可食用或口服药品或组合物的风味或口味调节剂,包括鲜味(味精的“鲜味”)或甜味调节剂,鲜味或甜味调味剂以及鲜味或甜味增强剂。
  • Synthesis and biological evaluation of novel shikonin-benzo[b]furan derivatives as tubulin polymerization inhibitors targeting the colchicine binding site
    作者:Yu-Ying Shao、Yong Yin、Bao-Ping Lian、Jia-Fu Leng、Yuan-Zheng Xia、Ling-Yi Kong
    DOI:10.1016/j.ejmech.2020.112105
    日期:2020.3
    with the IC50 value of 0.18 μM against HT29 cells, which was significantly better than that of the reference drugs shikonin and CA-4. What's more, 6c could inhibit tubulin polymerization and compete with [3H] colchicine in binding to tubulin. Further biological studies depicted that 6c can induce cell apoptosis and cell mitochondria depolarize, regulate the expression of apoptosis related proteins in
    设计并合成了一系列新的紫草素-苯并[b]呋喃衍生物作为微管蛋白聚合抑制剂,并对其生物学活性进行了评估。大多数化合物显示出与紫草素相当的抗癌细胞增殖活性,同时对非癌细胞具有较低的细胞毒性。其中,化合物6c对HT29细胞显示出强大的抗癌活性,IC50值为0.18μM,显着优于参考药物紫草素和CA-4。而且,6c可以抑制微管蛋白聚合,并与[3H]秋水仙碱竞争与微管蛋白的结合。进一步的生物学研究表明6c可以诱导细胞凋亡并使细胞线粒体去极化,调节HT29细胞中凋亡相关蛋白的表达。除了,6c激活了HT29细胞在G2 / M期的细胞周期停滞,并影响了细胞周期相关蛋白的表达。此外,6c显示出对细胞迁移和管形成的有效抑制,这有助于抗血管生成。这些结果促使我们将6c视为潜在的微管蛋白聚合抑制剂,值得进一步研究。
  • Catalytic Asymmetric Dearomatization by Visible‐Light‐Activated [2+2] Photocycloaddition
    作者:Naifu Hu、Hoimin Jung、Yu Zheng、Juhyeong Lee、Lilu Zhang、Zakir Ullah、Xiulan Xie、Klaus Harms、Mu‐Hyun Baik、Eric Meggers
    DOI:10.1002/anie.201802891
    日期:2018.5.22
    the catalytic asymmetric dearomatization by visible‐light‐activated [2+2] photocycloaddition with benzofurans and one example of a benzothiophene is reported, thereby providing chiral tricyclic structures with up to four stereocenters including quaternary stereocenters. The benzofurans and the benzothiophene are functionalized at the 2‐position with a chelating N‐acylpyrazole moiety which permits the
    报道了一种通过可见光活化的[2 + 2]光环加成与苯并呋喃和一个苯并噻吩实例进行催化不对称脱芳香化反应的新方法,从而提供了具有四个立体中心(包括四级立体中心)的手性三环结构。苯并呋喃和苯并噻吩在2位被N-酰基吡唑螯合部分官能化,从而允许可见光活化的手性铑路易斯手性酸催化剂的配位。计算分子模型揭示了异常区域选择性的起源,并确定了杂环中的杂原子是区域控制的关键。
  • Benzofuran Derivatives. I. On the Effects of Substituents in Benzofuran Syntheses
    作者:Tsuneo Suzuki、Takaaki Horaguchi、Takahachi Shimizu、Teishiro Abe
    DOI:10.1246/bcsj.56.2762
    日期:1983.9
    of 4-substituted 2-acylphenoxyacetic acids give a mixture of benzofurans and 2-benzofurancarboxylic acids. The relative yields of benzofurans and 2-benzofurancarboxylic acids depend on the substituents on the benzene ring of the 2-acylphenoxyacetic acids. Electron-withdrawing substituents such as nitro groups favor the formation of 2-benzofurancarboxylic acids. On the other hand, the formation of benzofurans
    4-取代的2-酰基苯氧基乙酸的Rossing反应得到苯并呋喃和2-苯并呋喃甲酸的混合物。苯并呋喃和 2-苯并呋喃甲酸的相对产率取决于 2-酰基苯氧乙酸苯环上的取代基。吸电子取代基如硝基有利于形成 2-苯并呋喃甲酸。另一方面,在 2-酰基-4-硝基苯氧乙酸与无水乙酸钠和乙酸酐的反应中,2-酰基的空间位阻有利于苯并呋喃的形成。
  • Modulation on C- and N-Terminal Moieties of a Series of Potent and Selective Linear Tachykinin NK<sub>2</sub>Receptor Antagonists
    作者:Martina Gensini、Maria Altamura、Tula Dimoulas、Valentina Fedi、Danilo Giannotti、Sandro Giuliani、Antonio Guidi、Nicholas J. S. Harmat、Stefania Meini、Rossano Nannicini、Franco Pasqui、Manuela Tramontana、Antonio Triolo、Carlo Alberto Maggi
    DOI:10.1002/cmdc.200900389
    日期:2010.1.4
    Herein we describe the synthesis of a series of new potent tachykinin NK2 receptor antagonists by the modulation of the C‐ and N‐terminal moieties of ibodutant (MEN 15596, 1). The N‐terminal benzo[b]thiophene ring was replaced by different substituted naphthalenes and benzofurans, while further modifications were evaluated at the C‐terminal tetrahydropyran moiety. Most compounds demonstrated a high affinity
    本文中,我们描述了一系列新的有效速激肽NK的合成2通过ibodutant的C-和N-末端部分的调制(MEN 15596,受体拮抗剂1)。N末端的苯并[ b ]噻吩环被不同的取代萘和苯并呋喃取代,同时在C末端的四氢吡喃部分评估了进一步的修饰。大多数化合物表现出对人NK 2受体的高亲和力和体外拮抗剂的高效力,表明可以在分子的两个末端引入广泛的取代基,而不会影响与NK 2受体的相互作用。对选定的化合物进行了体内测试,证实了其作为NK的活性2个拮抗剂。特别是,对豚鼠静脉内和静脉内给药后,化合物61b能够拮抗NK 2诱导的结肠收缩,其作用力和作用持续时间与参考化合物1(MEN 15596,ibodutant)完全相同。
查看更多

同类化合物

顺式-1-((2-(5-氯-2-苯并呋喃基)-4-甲基-1,3-二氧戊环-2-基)甲基)-1H-1,2,4-三唑 顺式-1-((2-(5,7-二氯-2-苯并呋喃基)-4-乙基-1,3-二氧戊环-2-基)甲基)-1H-咪唑 顺式-1-((2-(2-苯并呋喃基)-4-乙基-1,3-二氧戊环-2-基)甲基)-1H-1,2,4-三唑 霉酚酸酯杂质B 间甲酚紫 间甲基苯基(苯并呋喃-2-基)甲醇 长管假茉莉素C 金霉素 酪氨酸,b-羰基- 酞酸酐-d4 酚酞二丁酸酯 酚酞 酚红钠 酚红 邻苯二甲酸酐与马来酸酐,甘氨酰蜡素和二乙二醇的聚合物 邻苯二甲酸酐与己二醇的聚合物 邻苯二甲酸酐与三甘醇异壬醇的聚合物 邻苯二甲酸酐与2-乙基-2-羟甲基-1,3-丙二醇和2,5-呋喃二酮的聚合物 邻苯二甲酸酐与2-乙基-2-羟甲基-1,3-丙二醇、2,5-呋喃二酮和2-乙基己酸苯甲酸酯的聚合物 邻苯二甲酸酐-4-硼酸频哪醇酯 邻苯二甲酸酐,马来酸,二乙二醇,新戊二醇聚合物 邻甲酚酞 贝康唑 表灰黄霉素 螺佐呋酮 螺[苯并呋喃-3(2H),4-哌啶] 螺[异苯并呋喃-1(3H),4’-哌啶]-3-酮 螺[异苯并呋喃-1(3H),4'-哌啶]-3-酮盐酸盐 螺[异苯并呋喃-1(3H),3’-吡咯烷]-3-酮 螺[1-苯并呋喃-2,1'-环丙烷]-3-酮 薄荷内酯 莫罗卡尼 荨麻叶泽兰酮 荧光胺 苯酞-3-乙酸 苯酐二乙二醇共聚物 苯酐 苯甲酸,2-[(1,3-二羰基丁基)氨基]-,甲基酯 苯甲酸,2,2-二(羟甲基)丙烷-1,3-二醇,异苯并呋喃-1,3-二酮 苯甲酰氯化,3-甲氧基-4-甲基- 苯甲基(1-{(2-amino-2-methylpropanoyl)[(2S)-2-aminopropanoyl]amino}-2-methyl-1-oxopropan-2-yl)甲基氨基甲酸酯(non-preferredname) 苯并呋喃并[3,2-d]嘧啶-2,4(1H,3H)-二酮 苯并呋喃并[3,2-D]嘧啶-4(1H)-酮 苯并呋喃并[2,3-d]哒嗪-4(3H)-酮 苯并呋喃并(3,2-c)吡啶,1,2,3,4-四氢-2-(2-(二甲氨基)乙基)-,二盐酸 苯并呋喃与1H-茚的聚合物 苯并呋喃[3,2-b]吡咯-2-羧酸 苯并呋喃-7-羧酸 苯并呋喃-7-硼酸频那醇酯 苯并呋喃-7-甲腈